Overview

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Observe the effect of terlipressin on renal function in patients with SHR type I adjusting the dose based on hemodynamic response.
Phase:
Phase 4
Details
Lead Sponsor:
Pere Gines
Treatments:
Lypressin
Terlipressin